Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Brigitte Stanek"'
Autor:
Brigitte Stanek, Gerlinde Zorn, Petra Moser, Richard Pacher, Marianne Gwechenberger, M. Huelsmann, Rudolf Berger
Publikováno v:
The Journal of Heart and Lung Transplantation. 24:2190-2195
In patients with heart failure, B-type natriuretic peptides (BNP, N-BNP) and atrial natriuretic peptide (ANP) are established prognostic markers. However, circulating interleukin (IL)-6-related cytokines and soluble glycoprotein 130 (sgp130), their c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3089fd41e3d26eeb4350468e9ae484d9
https://doi.org/10.1016/j.healun.2004.10.015
https://doi.org/10.1016/j.healun.2004.10.015
Autor:
Rudolf Berger, Bernhard Frey, Anja Bojic, Richard Pacher, Petra Moser, Brigitte Stanek, M. Huelsmann, Karin Strecker
Publikováno v:
The Journal of Heart and Lung Transplantation. 22:1037-1045
Endothelin (ET) and natriuretic peptides have prognostic significance in chronic heart failure (CHF). Because stimuli for forming these neurohormones differ, this study investigates whether their prognostic power depends on clinical stage and on leng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32fd0f49826a2b0750ccea7e38dda0f5
https://doi.org/10.1016/s1053-2498(02)00560-0
https://doi.org/10.1016/s1053-2498(02)00560-0
Autor:
Wolfgang Woloszczuk, Andreas Zuckermann, Thomas Kos, Richard Pacher, Jeanette Strametz-Juranek, Brigitte Stanek, Michael Grimm
Publikováno v:
The Journal of Heart and Lung Transplantation. 22:731-737
The purpose of this study was to investigate the impact of successful heart transplantation in patients with refractory heart failure receiving bridging therapy on sequential plasma levels of big endothelin, norepinephrine, atrial natriuretic peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0711214e0d4a2666fb6e13c4c219c2
https://doi.org/10.1016/s1053-2498(02)00642-3
https://doi.org/10.1016/s1053-2498(02)00642-3
Autor:
Anja Bojic, Karin Strecker, Brigitte Stanek, Rudolf Berger, Richard Pacher, Petra Moser, Martin Huelsman
Publikováno v:
Circulation. 105:2392-2397
Background — Given the high incidence of sudden death in patients with chronic heart failure (CHF) and the efficacy of implantable cardioverter-defibrillators, an appropriate tool for the prediction of sudden death is desirable. B-type natriuretic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b72c2963ae029704fa2e3ad45ca7c18d
https://doi.org/10.1161/01.cir.0000016642.15031.34
https://doi.org/10.1161/01.cir.0000016642.15031.34
Autor:
Anja Bojic, Brigitte Stanek, Bernhard Frey, Barbara Sturm, Martin Hülsmann, Rudolf Berger, Richard Pacher
Publikováno v:
The Journal of Heart and Lung Transplantation. 20:1174-1180
We recently reported a beneficial clinical effect of atenolol, a beta(1) selective adrenergic antagonist, in 100 ambulatory heart failure patients with low left ventricular ejection fraction (LVEF,or=25%) who were receiving background therapy with 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cd0b5905555addddd8866cb7883cfdd
https://doi.org/10.1016/s1053-2498(01)00341-2
https://doi.org/10.1016/s1053-2498(01)00341-2
Autor:
Petra Moser, Rudolf Berger, Jutta Bergler-Klein, Anja Bojic, Jeanette Strametz-Juranek, Bernhard Frey, Martin Hülsmann, Richard Pacher, Barbara Sturm, Brigitte Stanek, Engelber Hartter
Publikováno v:
Journal of the American College of Cardiology. 38:436-442
The study assessed the relative predictive potency of neurohumoral factors in patients with advanced left ventricular (LV) dysfunction during neurohumoral blocking therapy.The course of heart failure is characterized by progressive LV deterioration a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab3126414ef25c2cf6582bbca42f369c
https://doi.org/10.1016/s0735-1097(01)01383-3
https://doi.org/10.1016/s0735-1097(01)01383-3
Autor:
Jeanette Strametz-Juranek, Richard Pacher, Barbara Sturm, Bernhard Frey, Brigitte Stanek, Rudolf Berger
Publikováno v:
European Journal of Heart Failure. 2:407-412
Background The survival benefit of β-blocker treatment in patients with heart failure has been established in recent trials. Yet, the impact of β-blockers added on high dose angiotensin converting enzyme inhibitors has not been reported. Aims To in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe51b484d3107bb54fb4b85638069d0
https://doi.org/10.1016/s1388-9842(00)00120-3
https://doi.org/10.1016/s1388-9842(00)00120-3
Autor:
Karin Strecker, Bernhard Frey, Martin Hülsmann, Rudolf Berger, Richard Pacher, Brigitte Stanek
Publikováno v:
The Journal of Heart and Lung Transplantation. 19:1081-1088
The aim of this study was to review our experience with beta-blocker therapy on top of high-dose angiotensin-converting enzyme inhibitors (ACE-I) in patients with advanced heart failure evaluated for heart transplantation, and to question the value o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0cccc56dbf36040e0bd4bdff8f58e1e
https://doi.org/10.1016/s1053-2498(00)00201-1
https://doi.org/10.1016/s1053-2498(00)00201-1
Autor:
Richard Pacher, Brigitte Stanek
Publikováno v:
Current Opinion in Cardiology. 15:156-160
Because of the standard use of oral neurohumoral antagonists, the role of intravenous agents for advanced heart failure patients has changed profoundly. Their current use as medical therapy is restricted to two indications: first, as short-term infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501c831d1ec8a5758ce73898cc957571
https://doi.org/10.1097/00001573-200005000-00006
https://doi.org/10.1097/00001573-200005000-00006
Autor:
Günther F. Wiesinger, Barbara Sturm, Michael Quittan, Brigitte Stanek, Richard Pacher, Bernhard Frey
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 80:746-750
Objective: To evaluate whether a specific program of moderate-intensity step aerobics training may be sufficient to improve the exercise tolerance of patients with severe chronic heart failure. Patients: Twenty-six patients (22 men, 4 women; mean ±
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0193071e72470583dcacb9fb06a90bb0
https://doi.org/10.1016/s0003-9993(99)90221-6
https://doi.org/10.1016/s0003-9993(99)90221-6